Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1

Conditions

Stomach Neoplasms 1Stomach Diseases 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Esophageal Neoplasms 1Esophageal Diseases 1Digestive System Neoplasms 1Digestive System Diseases 1

Interventions

Surveys and Questionnaires 4Nivolumab 3pembrolizumab 2cemiplimab 2atezolizumab 2amminedichloro(2-methylpyridine)platinum(II) 2Blood Specimen Collection 2trastuzumab deruxtecan 1trametinib 1repotrectinib 1pralsetinib 1pazopanib 1motexafin gadolinium 1durvalumab 1dabrafenib 1avelumab 1alectinib 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1Reverse Transcriptase Polymerase Chain Reaction 1Radiosurgery 1Quality of Life 1Patient-Specific Modeling 1Oncolytic Virotherapy 1Ocoxin 1Observation 1Mass Screening 1MLN 8237 1Immune Checkpoint Inhibitors 1Hyperspectral Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Ocoxin × Head & Neck × Clear all
NCT03549494 2024-02-07

Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction

Catalysis SL

Phase 2 Completed
45 enrolled
GastrointestinalHead & Neck

Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Stomach Diseases, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡